Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index; 14 of the 23 sources its claims cite were checked for support.

Retrospective Evaluation of Infants Aged 1 to 60 Days with Residual Cerebrospinal Fluid (CSF) Tested Using the FilmArray Meningitis/Encephalitis (ME) Panel

Open access

Abstract

In pediatric practice it is common for infants under 2 months of age to undergo evaluation for sepsis when they are ill, often including lumbar puncture to assess for central nervous system (CNS) infection. The FilmArray Meningitis/Encephalitis (ME) panel is a newly approved test for rapid identification of CNS pathogens. Our objective was to study the epidemiology of CNS infection in young infants and the potential impact of rapid multiplex PCR on their care. A performance evaluation of the FilmArray ME panel was conducted from February 2014 to September 2014 at 11 sites. FilmArray ME panel results were compared to reference standards but not shared with providers. In our study, medical records for infants (aged 1 to 60 days) enrolled at three sites were reviewed for clinical, laboratory, and outcome data. A total of 145 infants were reviewed. The median age was 25 days. Most of the infants were hospitalized (134/145 [92%]) and received antibiotics (123/145 [85%]), and almost half (71/145 [49%]) received acyclovir. One infant had a bacterial pathogen, likely false positive, identified by the FilmArray ME panel. Thirty-six infants (25%) had a viral pathogen detected, including 21 enteroviruses. All infants with enteroviral meningitis detected by the FilmArray ME panel and conventional PCR were hospitalized, but 20% were discharged in less than 24 h when conventional PCR results became available. The FilmArray ME panel may play a role in the evaluation of young infants for CNS infection. Results may be used to guide management, possibly resulting in a decreased length of stay and less antimicrobial exposure for infants with low-risk viral infection detected.

Overview

CoChat Summary

## TL;DR

This retrospective study reviewed 145 infants aged 1 to 60 days who had CSF tested with the FilmArray ME panel and found that the assay detected pathogens more often than conventional methods (37 vs 21 detections), but it also produced likely false positives. The authors conclude the panel may help guide management of young infants with CNS infection, especially viral cases such as enterovirus, while emphasizing careful interpretation.

## Key findings

  • Among 145 infants, the FilmArray ME panel identified pathogens in 37 (26%), compared with 21 (14%) by conventional methods.
  • Thirty-six infants (25%) had 37 viral pathogens detected in CSF; 36/37 (97%) were detected by FilmArray and 21/37 (57%) by conventional CSF testing.
  • Enterovirus was the most common virus detected: 21 of 36 virus-positive infants (58%); human parechovirus was next at 11 of 36 (31%).
  • Two FilmArray detections were likely false positives: one *Streptococcus pneumoniae* and one *Cryptococcus neoformans/C. gattii*; neither child had abnormal CSF studies or was diagnosed/treated for CNS infection.
  • Among 16 infants positive for enterovirus by both FilmArray and conventional PCR, all were hospitalized, 15/16 (94%) received antibiotics, 12/16 (75%) received acyclovir, and the median length of stay was 47 h.

## Methods

  • Retrospective review of medical records from infants aged 1 to 60 days who had enrolled in a prospective FilmArray ME panel performance study at 3 of 11 U.S. sites.
  • Sample: 145 infants with available PCR results and clinical data; the original performance study enrolled 1,560 subjects and the FilmArray panel was compared with standard-of-care CSF testing, but FilmArray results were not shared with clinicians.
  • Main analysis was descriptive comparison of FilmArray ME panel detections with conventional testing, plus review of clinical presentation, CSF findings, therapies, length of stay, and discharge diagnoses.

## Limitations

  • The authors state that the number of positive detections was limited and sample sizes were too small for statistical comparisons.
  • The study was retrospective, and FilmArray results were not available to providers; therefore the impact on management can only be inferred, not directly measured.
  • No infant had HSV detected, so the study could not evaluate the panel’s impact on HSV infection. Granular hospital cost data were also unavailable.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/jcm.00277-18

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

12 Valid · 2 Not valid · 4 Not checked · 62 Own results and interpretations

40 more claims · 1 with their cited sources checked

Create a free account to see all 80 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 20
  • Probably not a substantial claim. 18
  • Borderline: one of the tests for a substantial claim is unclear. 1
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 29 references

Cited by

See all 58

Metadata

Authors
Blaschke, A. J., Holmberg, K. M., Daly, J. A., Leber, A. L., Dien Bard, J., Korgenski, E. K., Bourzac, K. M., & Kanack, K. J.
Affiliations
  • University of Utah (US)
  • BioFire Diagnostics (United States) (US)
  • Primary Children's Hospital (US)
  • Nationwide Children's Hospital (US)
  • Children's Hospital of Los Angeles, Los Angeles, California, USA
  • Intermountain Healthcare (US)
Corresponding author
Blaschke, Anne J.
Venue
Journal of clinical microbiology
Published
2018-07
Volume
56
Issue
7
ISSN
  • 0095-1137 (ISSN-L)
  • 1098-660X
OpenAlex
W2801569283
Cited by
57
References
29
Citations by year
2026: 6 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 12 · 2021: 5 · 2020: 16 · 2019: 7 · 2018: 2
FWCI
7.14
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Clinical Microbiology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • BioFire Diagnostics
  • HHS | National Institutes of Health (1R03AI112865-01)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
Keywords
FilmArray Meningitis/Encephalitis panel, central nervous system infection, infants, meningitis, encephalitis, viral meningitis, enterovirus, sepsis evaluation, lumbar puncture, antimicrobial exposure, length of hospital stay, diagnostic performance
MeSH terms
Bacteria, Central Nervous System Infections, Cerebrospinal Fluid, Diagnostic Tests, Routine, Encephalitis, Female, Humans, Infant, Infant, Newborn, Male, Meningitis, Retrospective Studies, Time Factors, United States, Viruses, Molecular Diagnostic Techniques, Multiplex Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retrospective Evaluation of Infants Aged 1 to 60 Days with Residual Cerebrospinal Fluid (CSF) Tested Using the FilmArray Meningitis/Encephalitis (ME) Panel. https://app.cochat.ai/papers/10.1128/jcm.00277-18
The paper
Blaschke, A. J., Holmberg, K. M., Daly, J. A., Leber, A. L., Dien Bard, J., Korgenski, E. K., Bourzac, K. M., & Kanack, K. J. (2018). Retrospective Evaluation of Infants Aged 1 to 60 Days with Residual Cerebrospinal Fluid (CSF) Tested Using the FilmArray Meningitis/Encephalitis (ME) Panel. Journal of clinical microbiology. https://doi.org/10.1128/jcm.00277-18

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.